"In exploratory analyses, a single standard dose of ChAdOx1 nCoV-19 had an efficacy of 76 percent against symptomatic COVD-19 in the first 90 days after vaccination, with no significant waning of protection during this period," Lancet study said.Pharma wrap: Why India should consider extension of interval between two doses of Covishield vaccine
"In exploratory analyses, a single standard dose of ChAdOx1 nCoV-19 had an efficacy of 76 percent against symptomatic COVD-19 in the first 90 days after vaccination, with no significant waning of protection during this period," Lancet study said.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment